Provided by Tiger Trade Technology Pte. Ltd.

Lipella Pharmaceuticals Inc

0.1908
+0.019811.55%
Volume:1.17K
Turnover:221.72
Market Cap:852.16K
PE:-0.08
High:0.1908
Open:0.1908
Low:0.1908
Close:0.1710
52wk High:4.69
52wk Low:0.1650
Shares:4.47M
Float Shares:4.18M
Volume Ratio:0.23
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2600
EPS(LYR):-4.7857
ROE:-361.77%
ROA:-149.95%
PB:0.57
PE(LYR):-0.04

Loading ...

Company Profile

Company Name:
Lipella Pharmaceuticals Inc
Exchange:
PINK
Establishment Date:
2005
Employees:
6
Office Location:
7800 Susquehanna St.,Suite 505,Pittsburgh,Pennsylvania,United States
Zip Code:
15208
Fax:
- -
Introduction:
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.